Search
Powered By HealthLine
Health Tools
 Mood Tracker
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

New Hope for Trauma Injuries

Ivanhoe Newswire


(Ivanhoe Newswire) -- From roadside bombs to freeway crashes, traumatic injury is the leading cause of death for people age 4 to 44. Blood loss during trauma often overwhelms the body's natural blood-clotting process.

Case Western Reserve University biomedical engineering researchers Erin Lavik and James P. Bertram have developed synthetic platelets that combine with the bodys own natural platelets to halt internal and external bleeding in about half the normal time.

Text Continues Below



Lavik and Bertram were inspired by studies showing there are few treatment options for soldiers in Afghanistan and Iraq who suffer internal injuries. They wanted to develop a treatment medics can use in the field.

"The military has been phenomenal at developing technology to halt bleeding, but the technology has been effective only on external or compressible injuries," Lavik was quoted as saying. "This could be a complement to current therapies."

Blood platelets are the structural and chemical foundation of blood clotting, a complex cascade of events that works well with normal cuts and scrapes but can be overwhelmed by serious injury.
Using donor platelets can enhance clotting but carries the risk of complications. Donor platelets must be refrigerated, and they have a very short shelf life.

Bertram and Lavik developed platelets made from biodegradable polymers. The synthetic platelets are designed to link up with natural platelets at the site of an injury. The natural platelets, activated by injury, emit chemicals that bind natural platelets and the additional synthetics into a larger clot that quickly stems the bleeding.

Rat models injected with synthetic platelets prior to injury stopped bleeding in half the time of untreated models. Untreated models injected 20 seconds after injury stopped bleeding in 23 percent less time than models left untreated.
 
SOURCE: Science Translational Medicine, December 15, 2009


This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 12/30/2009

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2012. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire